Study characterizes vaginal misoprostol induction by severe obesity status

A randomized controlled trial published 14 October 2026 analysed 1322 term patients receiving the labor induction agent.

Stands on 1 first-party reading of PubMed and ClinicalTrials.gov, not reporting.

A randomized controlled trial comparing vaginal misoprostol labor induction in individuals with and without severe obesity has been published in the Journal of Maternal-Fetal & Neonatal Medicine. The study was indexed on PubMed on 14 October 2026^[1]. The trial included 1322 patients who received vaginal misoprostol for term labor induction between May 2021 and September 2022. 1058 patients, 80.0% of the cohort, had a BMI below 40 kg/m². 264 patients, 20.0% of the sample, had a BMI of 40 kg/m² or above. Authors reported effect sizes as odds ratios and adjusted mean differences with 95% confidence intervals. No further summary results were listed in the indexed abstract entry.

Proof1 source · 1 publisher · signed

What this stands on

"Characterizing vaginal misoprostol induction in individuals with and without severe obesity." published in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania... as a randomized controlled trial (PubMed 42875396, doi 10.1080/14767058.2026.2744004). Sample: 1322 as stated in the abstract. Duration: 37 weeks. Results as the authors report them: Effect sizes were presented as odds ratios and · PubMed and ClinicalTrials.gov, read by the New studies instrument · the fact recordUnited Statesofficial source

Read directly from PubMed and ClinicalTrials.gov, the public registries of published studies and registered trials, not from anyone's report of it.